Deconstructing the language of bleeding

Journal of the American College of Cardiology

Volumn 63, Issue 18, 2014, Pages 1876-1878

  Dauerman, Harold L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

acute myocardial infarction; BARC; bleeding

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FATALITY; HUMAN; NOTE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT PLANNING; VALIDATION STUDY; ACUTE HEART INFARCTION; HEART HEMODYNAMICS; HEART INFARCTION; INCIDENCE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; QUALITY OF LIFE;

ACUTE MYOCARDIAL INFARCTION; BARC; BLEEDING;

CORONARY OCCLUSION; FEMALE; HEMORRHAGE; HUMANS; MALE; MYOCARDIAL INFARCTION; STREPTOKINASE; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84899789110     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.02.558     Document Type: Editorial

References (11)

1. J.H. Chesebro, G. Knatterud, and R. Roberts et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76 1987 142 154
2. S.R. Steinhubl, A. Kastrati, and P.B. Berger Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs Am Heart J 154 2007 3 11
3. S.V. Rao, J. Eikelboom, and P.G. Steg et al. Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the Academic Bleeding Consensus (ABC) multidisciplinary working group Am Heart J 158 2009 881 886
4. R. Mehran, S.V. Rao, and D.L. Bhatt et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
5. K.A. Hicks, N.L. Stockbridge, S.L. Targum, and R.J. Temple Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspective Circulation 123 2011 2664 2665
6. W.J. Kikkert, N. van Geloven, and van der Laan et al. The prognostic value of Bleeding Academic Research Consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications J Am Coll Cardiol 63 2014 1866 1875
7. G. Ndrepepa, T. Schuster, and M. Hadamitzky et al. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention Circulation 125 2012 1424 1431
8. G.N. Levine, E.R. Bates, and J.C. Blankenship et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
9. A.P. Amin, A. Bachuwar, and K.J. Reid et al. Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status J Am Coll Cardiol 61 2013 2130 2138
10. H.L. Dauerman The softer side of bleeding J Am Coll Cardiol 61 2013 2139 2141
11. H.L. Dauerman, S.V. Rao, F.S. Resnic, and R.J. Applegate Bleeding avoidance strategies. Consensus and controversy J Am Coll Cardiol 58 2011 1 10